IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex reports sales jump on branded APIs

1:45 PM MDT | November 1, 2013 | Lindsay Frost

Cambrex today reported its third quarter results—with net income falling 8.6% year-over-year (YOY), to $17 million. The company reported income from continuing operations of 20 cts/share compared with 7 cts/share in the year-ago quarter. This is slightly below analyst estimates of 21 cts/share, according to Thomson Reuters (New York). Sales of $78 million were up 30% YOY and include a favorable foreign exchange benefit. Sales increased primarily due to higher sales of a large phase-3 product and certain branded active pharmaceutical ingredients (APIs)...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa